{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T17:42:02Z","timestamp":1771004522597,"version":"3.50.1"},"reference-count":53,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2003,12,1]],"date-time":"2003-12-01T00:00:00Z","timestamp":1070236800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cytokine"],"published-print":{"date-parts":[[2003,12]]},"DOI":"10.1016\/j.cyto.2003.09.003","type":"journal-article","created":{"date-parts":[[2003,10,28]],"date-time":"2003-10-28T16:24:20Z","timestamp":1067358260000},"page":"210-218","source":"Crossref","is-referenced-by-count":49,"title":["Cytokine production profile in patients with Behcet's disease treated with infliximab"],"prefix":"10.1016","volume":"24","author":[{"given":"Midori","family":"Misumi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eri","family":"Hagiwara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mitsuhiro","family":"Takeno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yukiko","family":"Takeda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuko","family":"Inoue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Tsuji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsuhisa","family":"Ueda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoshi","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shigeaki","family":"Ohno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshiaki","family":"Ishigatsubo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cyto.2003.09.003_BIB1","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1056\/NEJM199910213411707","article-title":"Behcet's disease","volume":"341","author":"Sakane","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cyto.2003.09.003_BIB2","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0049-0172(98)80001-2","article-title":"Behcet's disease","volume":"27","author":"Kaklamani","year":"1998","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.cyto.2003.09.003_BIB3","first-page":"1107","article-title":"TNF, soluble IL-2R and soluble CD8 in Behcet's disease","volume":"17","author":"Ako\u011flu","year":"1990","journal-title":"J Rheumatol"},{"key":"10.1016\/j.cyto.2003.09.003_BIB4","first-page":"1428","article-title":"Production of TNF-alpha and IL-1 in active Behcet disease","volume":"17","author":"Hamzaoui","year":"1990","journal-title":"J Rheumatol"},{"key":"10.1016\/j.cyto.2003.09.003_BIB5","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1046\/j.1365-2249.1999.01069.x","article-title":"Gammadelta T cells in Behcet's disease (BD) and recurrent aphthous stomatitis (RAS)","volume":"118","author":"Freysdottir","year":"1999","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.cyto.2003.09.003_BIB6","first-page":"1544","article-title":"Overproduction of monocyte derived tumor necrosis factor alpha, interleukin (IL)-6, IL-8 and increased neutrophil superoxide generation in Behcet's disease: a comparative study with familial Mediterranean fever and healthy subjects","volume":"20","author":"Mege","year":"1993","journal-title":"J Rheumatol"},{"key":"10.1016\/j.cyto.2003.09.003_BIB7","first-page":"321","article-title":"Cytokines in Behcet's disease","volume":"23","author":"Sayinalp","year":"1996","journal-title":"J Rheumatol"},{"key":"10.1016\/j.cyto.2003.09.003_BIB8","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1080\/09629350220131935","article-title":"Serum levels of TNF-alpha, sIL-2R, IL-6, and IL-8 are increased and associated with elevated lipid peroxidation in patients with Behcet's disease","volume":"11","author":"Evereklioglu","year":"2002","journal-title":"Mediators Inflamm"},{"key":"10.1016\/j.cyto.2003.09.003_BIB9","first-page":"975","article-title":"Cell biology in endogenous uveitis","volume":"101","author":"Nakamura","year":"1997","journal-title":"Nippon Ganka Gakkai Zasshi"},{"issue":"Suppl 2","key":"10.1016\/j.cyto.2003.09.003_BIB10","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1136\/ard.61.suppl_2.ii51","article-title":"Behcet's disease: a new target for anti-tumor necrosis factor treatment","volume":"61","author":"Sfikakis","year":"2002","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.cyto.2003.09.003_BIB11","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/S0140-6736(01)05497-6","article-title":"Effect of infliximab on sight-threatening panuveitis in Behcet's disease","volume":"358","author":"Sfikakis","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.cyto.2003.09.003_BIB12","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1136\/ard.61.6.560","article-title":"Anti-tumor necrosis factor monoclonal antibody treatment for ocular Behcet's disease","volume":"61","author":"Triolo","year":"2002","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.cyto.2003.09.003_BIB13","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1053\/gast.2001.22556","article-title":"Anti-tumor necrosis factor monoclonal antibody therapy for gastrointestinal Behcet's disease: a case report","volume":"120","author":"Hassard","year":"2001","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cyto.2003.09.003_BIB14","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1136\/gut.49.5.725","article-title":"Treatment of intestinal Behcet's syndrome with chimeric tumor necrosis factor \u03b1 antibody","volume":"49","author":"Travis","year":"2001","journal-title":"Gut"},{"key":"10.1016\/j.cyto.2003.09.003_BIB15","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1016\/S0140-6736(01)06677-6","article-title":"Effect of infliximab on threatening panuveitis in Behcet's disease","volume":"358","author":"Munoz-Fernandez","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.cyto.2003.09.003_BIB16","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1136\/ard.60.6.637","article-title":"Remission of Behcet's syndrome with tumor necrosis factor \u03b1 blocking therapy","volume":"60","author":"Goossens","year":"2001","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.cyto.2003.09.003_BIB17","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1093\/rheumatology\/40.4.473","article-title":"Treatment of recalcitrant orogenital ulceration of Behcet's syndrome with infliximab","volume":"40","author":"Robertson","year":"2001","journal-title":"Rheumatology"},{"key":"10.1016\/j.cyto.2003.09.003_BIB18","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1002\/1529-0131(199809)41:9<1552::AID-ART5>3.0.CO;2-W","article-title":"Therapeutic efficacy of multiple infusions of anti-tumor necrosis factor \u03b1 monoclonal antibody combined with low-dose weekly methotrexate in rheumatoid arthritis","volume":"41","author":"Maini","year":"1998","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.cyto.2003.09.003_BIB19","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1056\/NEJM199710093371502","article-title":"A short-term study of chimeric monoclonal antibody cA2 to tumor necrosis factor \u03b1 for Crohn's disease","volume":"337","author":"Targan","year":"1997","journal-title":"N Eng J Med"},{"key":"10.1016\/j.cyto.2003.09.003_BIB20","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1002\/1529-0131(199909)42:9<1967::AID-ANR24>3.0.CO;2-Z","article-title":"Th1 polarization of the immune response in Behcet's disease: a putative pathogenetic role of interleukin-12","volume":"42","author":"Franssanito","year":"1999","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.cyto.2003.09.003_BIB21","first-page":"996","article-title":"Increased frequencies of interleukin-2- and interferon-\u03b3-producing T cells in patients with active Behcet's disease","volume":"39","author":"Sugi-Ikai","year":"1998","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.cyto.2003.09.003_BIB22","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1159\/000309241","article-title":"Studies on spontaneous production of gamma-interferon in Behcet's disease","volume":"185","author":"Ohno","year":"1982","journal-title":"Ophtalmologica"},{"key":"10.1016\/j.cyto.2003.09.003_BIB23","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1111\/j.1346-8138.1998.tb02446.x","article-title":"The levels of plasma interleukin-2 and soluble interleukin-2R in Behcet's disease: a marker of disease activity","volume":"25","author":"Alpsoy","year":"1998","journal-title":"J Dermatol"},{"key":"10.1016\/j.cyto.2003.09.003_BIB24","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1080\/030097402320318387","article-title":"Cytokine profile in Behcet's disease patients: relationship with disease activity","volume":"31","author":"Hamzaoui","year":"2002","journal-title":"Scand J Rheumatol"},{"key":"10.1016\/j.cyto.2003.09.003_BIB25","first-page":"329","article-title":"Divergent cytokine production profile in Behcet's disease: altered Th1\/Th2 cell cytokine pattern","volume":"25","author":"Raziuddin","year":"1998","journal-title":"J Rheumatol"},{"key":"10.1016\/j.cyto.2003.09.003_BIB26","first-page":"128","article-title":"Systemic levels of the T cell regulatory cytokines IL-10 and IL-12 in Behcet's disease: soluble TNFR-75 as a biological marker of disease activity","volume":"24","author":"Turan","year":"1997","journal-title":"J Rheumatol"},{"key":"10.1016\/j.cyto.2003.09.003_BIB27","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1212\/WNL.47.6.1531","article-title":"Increased MRI activity and immune activation in two multiple sclerosis patients treated with the monoclonal anti-tumor necrosis factor antibody cA2","volume":"47","author":"van Oosten","year":"1996","journal-title":"Neurology"},{"key":"10.1016\/j.cyto.2003.09.003_BIB28","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1212\/WNL.53.3.457","article-title":"TNF neutralization in MS: results of a randomized, placebo-controlled multicenter study","volume":"53","author":"The Lenercept Multiple Sclerosis Study Group and The University of British Columbia MS\/MRI Analysis Group","year":"1999","journal-title":"Neurology"},{"key":"10.1016\/j.cyto.2003.09.003_BIB29","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1212\/WNL.57.10.1885","article-title":"Onset of multiple sclerosis associated with anti-TNF therapy","volume":"57","author":"Sicotte","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/j.cyto.2003.09.003_BIB30","doi-asserted-by":"crossref","first-page":"2862","DOI":"10.1002\/1529-0131(200112)44:12<2862::AID-ART474>3.0.CO;2-W","article-title":"Demyelination occurring during anti-tumor necrosis factor \u03b1 therapy for inflammatory arthritides","volume":"44","author":"Mohan","year":"2001","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.cyto.2003.09.003_BIB31","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1002\/1529-0131(200109)44:9<1977::AID-ART345>3.0.CO;2-6","article-title":"Demyelinating and neurologic events reported in association with tumor necrosis factor \u03b1 antagonism: by what mechanisms could tumor necrosis factor \u03b1 antagonists improve rheumatoid arthritis but exacerbate multiple sclerosis?","volume":"44","author":"Robinson","year":"2001","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.cyto.2003.09.003_BIB32","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1136\/ard.60.8.750","article-title":"Impaired Th1 cytokine production in spondyloarthropathy is restored by anti-TNF\u03b1","volume":"60","author":"Baeten","year":"2001","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.cyto.2003.09.003_BIB33","doi-asserted-by":"crossref","first-page":"2166","DOI":"10.1002\/1529-0131(199910)42:10<2166::AID-ANR18>3.0.CO;2-K","article-title":"Treatment with monoclonal anti-tumor necrosis factor alpha antibody results in an accumulation of Th1 CD4+ T cells in the peripheral blood of patients with rheumatoid arthritis","volume":"42","author":"Maurice","year":"1999","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.cyto.2003.09.003_BIB34","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0065-2776(08)60387-9","article-title":"Interleukin-12: a cytokine at the interface of inflammation and immunity","volume":"70","author":"Trinchieri","year":"1998","journal-title":"Adv Immunol"},{"key":"10.1016\/j.cyto.2003.09.003_BIB35","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1146\/annurev.immunol.16.1.495","article-title":"The interleukin-12\/interleukin-12-receptor system: role in normal and pathogenetic immune responses","volume":"16","author":"Gately","year":"1998","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.cyto.2003.09.003_BIB36","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S0022-1759(97)00019-7","article-title":"The use of computer-associated video image analysis for the quantification of CD8+ T lymphocytes producing tumor necrosis factor \u03b1 spots in response to peptide antigens","volume":"203","author":"Herr","year":"1997","journal-title":"J Immunol Methods"},{"key":"10.1016\/j.cyto.2003.09.003_BIB37","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1006\/cyto.1995.0098","article-title":"Phenotype and frequency of cells secreting IL-2, IL-4, IL-6, IL-10, IFN and TNF-\u03b1 in human peripheral blood","volume":"7","author":"Hagiwara","year":"1995","journal-title":"Cytokine"},{"key":"10.1016\/j.cyto.2003.09.003_BIB38","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0022-1759(89)90281-0","article-title":"The detection and enumeration of cytokine-secreting cells in mice and man and the clinical application of these assays","volume":"120","author":"Hutchings","year":"1989","journal-title":"J Immunol Methods"},{"key":"10.1016\/j.cyto.2003.09.003_BIB39","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1006\/cyto.1995.0029","article-title":"Chimeric anti-TNF-alpha monoclonal antibody cA2 binds recombinant transmembrane TNF-alpha and activates immune effector functions","volume":"7","author":"Scallon","year":"1995","journal-title":"Cytokine"},{"key":"10.1016\/j.cyto.2003.09.003_BIB40","first-page":"19","article-title":"Infliximab (Remicade) for Crohn's disease","volume":"41","year":"1999","journal-title":"Med Lett Drugs Ther"},{"key":"10.1016\/j.cyto.2003.09.003_BIB41","doi-asserted-by":"crossref","first-page":"201","DOI":"10.3109\/08916939209148460","article-title":"CD4+ lymphocyte involvement in ocular BD","volume":"12","author":"Charteris","year":"1992","journal-title":"Autoimmunity"},{"key":"10.1016\/j.cyto.2003.09.003_BIB42","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1046\/j.1365-2559.2000.00859.x","article-title":"Neutrophil and endothelial cell activation in the vasa vasorum in vasculo-Behcet's disease","volume":"36","author":"Kobayashi","year":"2000","journal-title":"Histopathology"},{"key":"10.1016\/j.cyto.2003.09.003_BIB43","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1046\/j.1365-2249.1998.00572.x","article-title":"Abnormal T cell responses to bacterial superantigens in Behcet's disease (BD)","volume":"112","author":"Hirohata","year":"1998","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.cyto.2003.09.003_BIB44","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1002\/art.1780390702","article-title":"Decrease in cellularity and expression of adhesion molecules by anti-tumor necrosis factor alpha monoclonal antibody treatment in patients with rheumatoid arthritis","volume":"39","author":"Tak","year":"1996","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.cyto.2003.09.003_BIB45","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1002\/art.1780390703","article-title":"Deactivation of vascular endothelium by monoclonal anti-tumor necrosis factor alpha antibody in rheumatoid arthritis","volume":"39","author":"Paleolog","year":"1996","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.cyto.2003.09.003_BIB46","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1159\/000237393","article-title":"What is the mechanism of action of anti-tumor necrosis factor-\u03b1 antibody in rheumatoid arthritis?","volume":"111","author":"Feldmann","year":"1996","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1016\/j.cyto.2003.09.003_BIB47","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1002\/1529-0131(200001)43:1<38::AID-ANR6>3.0.CO;2-L","article-title":"Reduction of chemokine levels and leukocyte traffic to joints by tumor necrosis factor \u03b1 blockade in patients with rheumatoid arthritis","volume":"43","author":"Taylor","year":"2000","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.cyto.2003.09.003_BIB48","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.4049\/jimmunol.156.4.1646","article-title":"In vivo blockade of TNF-\u03b1 by intravenous infusion of a chimeric monoclonal TNF-\u03b1 antibody in patients with rheumatoid arthritis: short term cellular and molecular effects","volume":"156","author":"Lorenz","year":"1996","journal-title":"J Immunol"},{"key":"10.1016\/j.cyto.2003.09.003_BIB49","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1172\/JCI117394","article-title":"Chronic exposure to tumor necrosis factor (TNF) in vitro impairs the activation of T cells through the T cell receptor\/CD3 complex; reversal in vivo by anti-TNF antibodies in patients with rheumatoid arthritis","volume":"94","author":"Cope","year":"1994","journal-title":"J Clin Invest"},{"key":"10.1016\/j.cyto.2003.09.003_BIB50","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1136\/ard.60.2.133","article-title":"Increased peripheral T cell reactivity to microbial antigens and collagen type II in rheumatoid arthritis after treatment with soluble TNF\u03b1 receptors","volume":"60","author":"Berg","year":"2001","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.cyto.2003.09.003_BIB51","doi-asserted-by":"crossref","first-page":"5495","DOI":"10.4049\/jimmunol.166.9.5495","article-title":"Prolonged exposure of T cells to TNF down-regulates TCR\u03b6 and expression of the TCR\/CD3 complex at the cell surface","volume":"166","author":"Isomaki","year":"2001","journal-title":"J Immunol"},{"key":"10.1016\/j.cyto.2003.09.003_BIB52","doi-asserted-by":"crossref","first-page":"2189","DOI":"10.1172\/JCI117215","article-title":"Anti-tumor necrosis factor modulates anti-CD3-triggered T cell cytokine gene expression in vivo","volume":"93","author":"Ferran","year":"1994","journal-title":"J Clin Invest"},{"key":"10.1016\/j.cyto.2003.09.003_BIB53","first-page":"1078","article-title":"Criteria for diagnosis of Behcet's disease","volume":"335","author":"International Study Group for Behcet's Disease","year":"1990","journal-title":"Lancet"}],"container-title":["Cytokine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466603003156?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466603003156?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,4,27]],"date-time":"2023-04-27T08:46:27Z","timestamp":1682585187000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043466603003156"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,12]]},"references-count":53,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2003,12]]}},"alternative-id":["S1043466603003156"],"URL":"https:\/\/doi.org\/10.1016\/j.cyto.2003.09.003","relation":{},"ISSN":["1043-4666"],"issn-type":[{"value":"1043-4666","type":"print"}],"subject":[],"published":{"date-parts":[[2003,12]]}}}